MARKET

AMGN

AMGN

Amgen Inc
NASDAQ
329.89
-10.27
-3.02%
After Hours: 330.70 +0.81 +0.25% 19:58 12/05 EST
OPEN
340.36
PREV CLOSE
340.16
HIGH
340.88
LOW
328.63
VOLUME
2.90M
TURNOVER
--
52 WEEK HIGH
346.38
52 WEEK LOW
245.31
MARKET CAP
177.64B
P/E (TTM)
25.50
1D
5D
1M
3M
1Y
5Y
1D
Dividend Champion, Contender, And Challenger Highlights: Week Of December 7
Seeking Alpha · 5h ago
Validea Detailed Fundamental Analysis - AMGN
NASDAQ · 16h ago
A Closer Look at Amgen (AMGN) Valuation After Its 12-Month 28% Share Price Gain
Simply Wall St · 16h ago
SCHD, AMGN, BMY, LMT: ETF Inflow Alert
NASDAQ · 19h ago
Amgen upgraded to Buy from Hold at Erste Group
TipRanks · 20h ago
Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock
NASDAQ · 21h ago
Salesforce (CRM) Wins AstraZeneca Deal, Becomes the Unified Global Platform
TipRanks · 1d ago
Salesforce posts impressive results but lands last in Dow 30 SA Quant Ratings
Seeking Alpha · 1d ago
More
About AMGN
Amgen Inc. is a biotechnology company. It discovers, develops, manufactures and delivers medicines for the toughest diseases. It focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve people’s lives. It operates in the human therapeutics segment. Its marketed products portfolio includes EPOGEN (epoetin alfa); Aranesp (darbepoetin alfa); Parsabiv (etelcalcetide); Neulasta (pegfilgrastim); KANJINTI (trastuzumab-anns); Otezla; BLINCYTO (blinatumomab); ACTIMMUNE (interferon gamma-1b); Neulasta (pegfilgrastim); Sensipar/Mimpara (cinacalcet); Prolia (denosumab); ENBREL; QUINSAIR (levofloxacin); Repatha (evolocumab) and others. It markets ENBREL, a tumor necrosis factor blocker, in the United States and Canada. It markets Otezla, a small molecule that inhibits phosphodiesterase 4, in many countries around the world. It markets Repatha, a proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor, in many countries around the world.

Webull offers Amgen Inc stock information, including NASDAQ: AMGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AMGN stock methods without spending real money on the virtual paper trading platform.